(Press-News.org) ST. PAUL, Minn. – New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures. The research is published in the August 31, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Despite some limitations, our results suggest that the choice of seizure medications in brain tumor patients should be carefully considered as it may give people a few more months with their loved ones," said study author Michael Weller, MD, with the University Hospital Zurich in Switzerland and a member of the American Academy of Neurology.
Seizures occur in up to half of all people with glioblastomas, the most common and most malignant brain tumor in adults. For those patients with seizures, treatment with one of several epilepsy drugs is highly recommended. After surgery, standard treatment for patients with newly diagnosed glioblastoma is radiation therapy together with the chemotherapy drug temozolomide.
For this study, researchers with the European Organization for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada Clinical Trials Group (NCIC) analyzed the use of epilepsy drugs by 573 brain tumor patients who had been enrolled in a clinical trial evaluating radiation therapy with and without temozolomide. When treatment started, 175 were not taking a seizure drug, while 398 patients were on anti-seizure medicine, including 97 patients who were taking valproic acid as their sole anti-seizure medication.
While the study showed that patients being treated with both chemotherapy and radiation fare better, those patients who also received valproic acid as medication for seizure prevention had an even further improved outcome, living an average of three months longer compared to those not receiving the drug.
While survival increased, people taking valproic acid in addition to radiation therapy and temozolomide were more likely than the other groups to experience a drop in blood platelets and white blood cells, which can increase a person's risk of bleeding and infection.
Taking valproic acid did not benefit survival in the group that received radiation therapy alone without temozolomide. Weller said that the use of valproic acid and other drugs with a similar mechanism should be further studied in order to determine whether and why valproic acid may help patients who are receiving radiation therapy and temozolomide live longer.
###
The study was supported by the National Cancer Institute in the United States and a grant from the Swiss Cancer League to the European Organization for Research and Treatment of Cancer Charitable Trust in Switzerland.
The American Academy of Neurology, an association of more than 24,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia.
For more information about the American Academy of Neurology, visit http://www.aan.com.
VIDEO:
http://www.youtube.com/AANChannel
TEXT:
http://www.aan.com/press
TWEETS:
http://www.twitter.com/AANPublic
END
An investigation into the mysterious inner workings of the malaria parasite has revealed that it survives and proliferates in the human bloodstream thanks in part to a single, crucial chemical that the parasite produces internally.
According to scientists at the University of California, San Francisco (UCSF) and Stanford Medical School, reporting today in the journal PLoS Biology, this insight immediately provides a powerful new tool for discovering and designing drugs to treat malaria, which infects hundreds of millions of people around the world each year and claims ...
Hamilton, ON (August 31, 2011) – Scientists were surprised at how fast bacteria developed resistance to the miracle antibiotic drugs when they were developed less than a century ago. Now scientists at McMaster University have found that resistance has been around for at least 30,000 years.
Research findings published today in the science journal Nature show antibiotic resistance is a natural phenomenon that predates the modern clinical antibiotic use. Principal investigators for the study are Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious ...
In this month's edition of Physics World, David Wilkinson, visiting fellow at Nottingham Trent University and former project manager in the UK Home Office Scientific Development Branch, explains how physics is at the forefront of police weapons testing, making sure that potential devices meet the strict criteria set out by the UK government.
Modern police weapons, such as CS gas and TASERs, are often referred to as "less-lethal weapons" because they are designed to effectively stop people with minimum risk to both suspects and officers, and are less brutal than traditional ...
A study involving nearly 10,000 cardiac arrest patients from 10 North American regions has shown that extending the period of initial cardiopulmonary resuscitation (CPR) by paramedics and firefighters from one to three minutes provides no benefit. The study, led by Dr. Ian Stiell of the Ottawa Hospital Research Institute (OHRI), the University of Ottawa (uOttawa) and the Resuscitation Outcomes Consortium (ROC), resolves a worldwide controversy about cardiac arrest care. It is the largest randomized cardiac arrest trial in the world, published in the New England Journal ...
Researchers have undertaken the most comprehensive investigation of genetic variance in human metabolism and discovered new insights into a range of common diseases. Their work has revealed 37 new variants that are associated with concentrations of metabolites in the blood. Many of these match variants associated with diseases such as chronic kidney disease, type 2 diabetes and blood clotting.
The team conducted the largest ever study of the human genome for genetic variants associated with metabolites - the biochemical compounds representing the start or end of metabolic ...
A new study suggests that Homo erectus, a precursor to modern humans, was using advanced toolmaking methods in East Africa 1.8 million years ago, at least 300,000 years earlier than previously thought. The study, published this week in Nature, raises new questions about where these tall and slender early humans originated and how they developed sophisticated tool-making technology.
Homo erectus appeared about 2 million years ago, and ranged across Asia and Africa before hitting a possible evolutionary dead-end, about 70,000 years ago. Some researchers think Homo erectus ...
A faint star in the constellation of Leo (The Lion), called SDSS J102915+172927 [1], has been found to have the lowest amount of elements heavier than helium (what astronomers call "metals") of all stars yet studied. It has a mass smaller than that of the Sun and is probably more than 13 billion years old.
"A widely accepted theory predicts that stars like this, with low mass and extremely low quantities of metals, shouldn't exist because the clouds of material from which they formed could never have condensed," [2] said Elisabetta Caffau (Zentrum fur Astronomie der Universitat ...
For the first time, researchers at the University of California, Davis, have demonstrated that forest trees have the ability to tap into nitrogen found in rocks, boosting the trees' growth and their ability to pull more carbon dioxide from the atmosphere.
Given that carbon dioxide is the most important climate-change gas, the nitrogen in rocks could significantly affect how rapidly the earth will warm in the future, the researchers say. They report their findings in the Sept. 1 issue of the scientific journal Nature.
If trees can access more nitrogen than previously ...
VIDEO:
This three-dimensional reconstruction of part of a human colorectal tumor shows widespread infection with oncolytic vaccinia virus (green).
Click here for more information.
Researchers from the Ottawa Hospital Research Institute (OHRI), the University of Ottawa (uOttawa), Jennerex Inc. and several other institutions today reported promising results of a world-first cancer therapy trial in renowned journal Nature. The trial is the first to show that an intravenously-delivered ...
STANFORD, Calif. — Memo to mature, health-minded vampires: You might want to consider limiting your treats to victims under age 30.
In a study to be published Sept. 1 in Nature, Stanford University School of Medicine scientists have found substances in the blood of old mice that makes young brains act older. These substances, whose levels rise with increasing age, appear to inhibit the brain's ability to produce new nerve cells critical to memory and learning.
The findings raise the question of whether it might be possible to shield the brain from aging by eliminating ...
